US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Anti-Pandemic Concept

1,328.15

-73.3986-5.24%

Number of Gainers:4

Number of Losers:16

Number of Flat:- -

PE:- -

High:1,393.19

Open:1,393.19

Low:1,326.93

Close:1,401.55

Loading ...

Deutsche Euroshop (0I3Z) Gets a Hold from Warburg Research

Jim Cramer Calls Moderna (MRNA) ‘Problematic’

Pfizer (NYSE:PFE) Involved In Lawsuit Over US$45 Per Share Cerevel Acquisition

Simply Wall St.

Johnson & Johnson Faces Legal Hurdles: Stock Tumbles

Pfizer Faces Stock Slump Amidst Regulatory Challenges

Will Weakness in Abbott Laboratories' (NYSE:ABT) Stock Prove Temporary Given Strong Fundamentals?

Simply Wall St.

BioNTech SE Announces Virtual Annual General Meeting for 2025

The FDA Is Being Gutted. 'People Are Going to Die.' -- Barrons.com

AstraZeneca (LSE:AZN) Secures EU Approvals; $125 Million Payment Due to Daiichi Sankyo

Simply Wall St.

European Drug Regulator Approves AstraZeneca's Two Flagship Cancer Drugs For Breast And Lung Cancer Settings

BUZZ-US medical device makers fall as China retaliates to US tariffs

Pfizer Inc. (PFE) – Jim Cramer Declares: ‘Dead Money – Close the Casket!’

Is Abbott (ABT) a Buy as Wall Street Analysts Look Optimistic?

Almonty Industries Inc. Confirms No Impact from Recent U.S. Executive Order on Reciprocal Tariffs

Lakeland Industries (LAKE) Receives a Buy from Roth MKM

4 Low-Beta Healthcare Stocks to Beat Trump's Tariff Blues

Reasons to Add ABT Stock to Your Portfolio Right Now

TREMFYA® (guselkumab) is the first and only IL-23 inhibitor to significantly reduce both the signs and symptoms and the progression of structural damage in adults living with active psoriatic arthritis

AstraZeneca PLC's (LON:AZN) Stock Has Fared Decently: Is the Market Following Strong Financials?

Simply Wall St.

Thermo Fisher Stock Benefits From the Launch of Krios 5 Cryo-TEM

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BK4568/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4568","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","market":"US","secType":"PLATE","nameCN":"Anti-Pandemic Concept","latestPrice":1328.1475,"timestamp":1743796799999,"preClose":1401.546,"halted":0,"volume":168106364,"delay":0,"changeRate":-0.05237,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Market Closed","change":-73.39856,"latestTime":"04-04 16:00:00 EDT","open":1393.1852,"high":1393.1852,"low":1326.9338,"amount":8439035420.533051,"amplitude":0.04727,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Market Trading","tradingStatus":1,"beginTime":1744012800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":3.807911,"peRate":30.440853,"turnoverRate":0.010852,"increases":4,"decrements":16,"flats":0,"marketCap":1094675987146,"floatMarketCap":1077197187869.5},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","high":1393.1852,"amplitude":0.04727,"preClose":1401.546,"low":1326.9338,"pbRate":"3.807911","latestPrice":1328.1475,"volume":168106364,"delay":0,"open":1393.1852,"prevYearClose":1274.8187,"prevWeekClose":1419.4854,"prevMonthClose":1427.887,"prevQuarterClose":1427.887,"fiveDayClose":1419.4854,"twentyDayClose":1480.0557,"sixtyDayClose":1290.6007,"secType":"PLATE","market":"US","turnoverRate":0.010852,"peRate":30.440853,"marketCap":1094675987146,"floatMarketCap":1077197187869.5,"timestamp":1743796799999,"nameCN":"Anti-Pandemic Concept"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4568\",,,,undefined,":{"bkCode":"BK4568","up":4,"down":16,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4568\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2525974949","title":"Deutsche Euroshop (0I3Z) Gets a Hold from Warburg Research","url":"https://stock-news.laohu8.com/highlight/detail?id=2525974949","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525974949?lang=en_us&edition=fundamental","pubTime":"2025-04-06 08:05","pubTimestamp":1743897905,"startTime":"0","endTime":"0","summary":"In a report released on April 2, Andreas Plaesier from Warburg Research maintained a Hold rating on Deutsche Euroshop (0I3Z – Research Report), wit...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/deutsche-euroshop-0i3z-gets-a-hold-from-warburg-research?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/deutsche-euroshop-0i3z-gets-a-hold-from-warburg-research?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4548","BK4139","BK4588","BK4551","BNTX","BK4535","BK4585","BK4568"],"gpt_icon":0},{"id":"2525746917","title":"Jim Cramer Calls Moderna (MRNA) ‘Problematic’","url":"https://stock-news.laohu8.com/highlight/detail?id=2525746917","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525746917?lang=en_us&edition=fundamental","pubTime":"2025-04-06 06:34","pubTimestamp":1743892473,"startTime":"0","endTime":"0","summary":"We recently published a list of Jim Cramer Says Wait A Little & Discusses These 11 Stocks. In this article, we are going to take a look at where Moderna, Inc.  stands against other stocks that Jim Cramer discusses.In a recent appearance on CNBC’s Squawk on the Street, Jim Cramer commented on the increasing bearishness in the stock market. His co-host Carl Quintanilla asked Cramer about Cramer’s observations about the ratio of price target cuts versus raises. In response, Cramer replied:. Cramer also shared an interesting trading strategy from his personal life. He revealed that at the end of every month, he contributes to an S&P fund as he can’t directly buy stocks. However, when asked why he thought to wait this time around, Cramer replied: “Because I can’t think of a dumber day to buy. Okay, sorry. . .I debated ending the show there, but I think there’s a better day to buy. It’s not just yet.”","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/jim-cramer-calls-moderna-mrna-223433812.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["USAW.SI","QID","PSQ","BK4533","US12M.BOND","US30Y.BOND","US7Y.BOND","BK4139","MRNA","BK4532",".IXIC","USJW.SI","SQQQ","NVIW.SI","BK4548","US5Y.BOND","QLD","TQQQ","BK4534","US3Y.BOND","US2Y.BOND","US10Y.BOND","BK4551","TSYW.SI","BK4585","US6M.BOND","BK4501","BK4588","NQmain","BK4568","MNQmain"],"gpt_icon":1},{"id":"2525714416","title":"Pfizer (NYSE:PFE) Involved In Lawsuit Over US$45 Per Share Cerevel Acquisition","url":"https://stock-news.laohu8.com/highlight/detail?id=2525714416","media":"Simply Wall St.","labels":["policyRegulatory","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525714416?lang=en_us&edition=fundamental","pubTime":"2025-04-06 01:41","pubTimestamp":1743874893,"startTime":"0","endTime":"0","summary":"In recent developments, a class action lawsuit was filed against Cerevel Therapeutics, Bain Capital Investors, and Pfizer, citing alleged securities violations related to Cerevel's stock offering. This legal issue may have influenced Pfizer's recent stock activity, where shares fell 9% over the past week. Additionally, broader market dynamics played a role, as major indices plunged amidst fears of a trade war with China, affecting investor sentiment and contributing to the general downturn. While Pfizer also received marketing authorization for its RSV vaccine in Europe, these positive news items were overshadowed by the pervasive market setbacks, driving the stock decline.We've spotted 3 possible red flags for Pfizer you should be aware of, and 2 of them make us uncomfortable.NYSE:PFE Revenue & Expenses Breakdown as at Apr 2025. Over the last year, Pfizer's total shareholder return, which includes share price and dividends, recorded an 8.44% decline. This figure underperformed both th","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/pfizer-nyse-pfe-involved-lawsuit-174133461.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory,merge","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0321505439.SGD","IE00B19Z3B42.SGD","LU1066053197.SGD","SG9999002224.SGD","LU0170899867.USD","LU1883839398.USD","BK4568","LU1894683348.USD","SG9999001176.SGD","SG9999011175.SGD","LU1894683264.USD","LU0985481810.HKD","BK4592","BK4581","BK4588","LU0234572021.USD","SG9999003800.SGD","SGXZ57979304.SGD","PFE","IE0002270589.USD","IE000M9KFDE8.USD","LU0306806265.USD","LU1023059063.AUD","LU0058720904.USD","NYSE","SG9999002232.USD","LU0456855351.SGD","LU0225284248.USD","LU1066051498.USD","BK4550","IE00BLSP4452.SGD","LU1057294990.SGD","BK4007","LU0868494617.USD","LU0289739699.SGD","LU0122379950.USD","BK4533","IE00BBT3K403.USD","BK4534","LU0225771236.USD","LU0321505868.SGD","IE00BLSP4239.USD","BK4599","BK4585","IE00B19Z3581.USD","LU0306807586.USD","SG9999001176.USD","SG9999013999.USD"],"gpt_icon":1},{"id":"2525713469","title":"Johnson & Johnson Faces Legal Hurdles: Stock Tumbles","url":"https://stock-news.laohu8.com/highlight/detail?id=2525713469","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525713469?lang=en_us&edition=fundamental","pubTime":"2025-04-05 22:04","pubTimestamp":1743861842,"startTime":"0","endTime":"0","summary":"Johnson & Johnson ( ($JNJ) ) has fallen by -7.60%. Read on to learn why. Johnson & Johnson’s stock has experienced a notable decline of 7.60% over ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/weekend-updates/johnson-johnson-faces-legal-hurdles-stock-tumbles?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/weekend-updates/johnson-johnson-faces-legal-hurdles-stock-tumbles?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0345769128.USD","BK4559","IE00B42XCP33.USD","LU1506573853.SGD","SG9999002224.SGD","BK4534","LU2430703178.SGD","LU0345770308.USD","LU1718418525.SGD","IE0002270589.USD","LU2505996681.GBP","IE00B19Z3B42.SGD","LU0203347892.USD","LU2430703251.USD","IE00B3PB1722.GBP","BK4550","LU1059921491.USD","IE0009355771.USD","BK4533","LU0345770993.USD","LU1061106388.HKD","LU1732799900.SGD","IE00BJJMRZ35.SGD","IE00B3T34201.USD","LU1066053197.SGD","LU1914381329.SGD","IE00BFTCPJ56.SGD","LU0234570918.USD","LU1894683264.USD","LU1221951046.USD","LU1244550221.USD","LU0795875086.SGD","BK4532","IE00BVYPNW00.USD","LU2129689514.USD","BK4585","LU0912757837.SGD","IE0034235303.USD","IE00BGHQF631.EUR","LU1261432733.SGD","LU2347655156.SGD","LU2430703095.HKD","LU2592432038.USD","JNJ","LU0203345920.USD","LU0098860793.USD","LU0320765646.SGD","LU1244550577.SGD","LU1778281490.HKD","BK4568"],"gpt_icon":0},{"id":"2525713438","title":"Pfizer Faces Stock Slump Amidst Regulatory Challenges","url":"https://stock-news.laohu8.com/highlight/detail?id=2525713438","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525713438?lang=en_us&edition=fundamental","pubTime":"2025-04-05 22:02","pubTimestamp":1743861776,"startTime":"0","endTime":"0","summary":"Pfizer ( ($PFE) ) has fallen by -9.35%. Read on to learn why. Pfizer’s stock has experienced a significant decline of 9.35% over the past week, ref...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/weekend-updates/pfizer-faces-stock-slump-amidst-regulatory-challenges?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/weekend-updates/pfizer-faces-stock-slump-amidst-regulatory-challenges?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0321505439.SGD","IE00B19Z3B42.SGD","LU1066053197.SGD","SG9999002224.SGD","LU0170899867.USD","LU1883839398.USD","BK4568","LU1894683348.USD","SG9999001176.SGD","SG9999011175.SGD","LU1894683264.USD","LU0985481810.HKD","BK4592","BK4581","BK4588","LU0234572021.USD","SG9999003800.SGD","SGXZ57979304.SGD","PFE","IE0002270589.USD","IE000M9KFDE8.USD","LU0306806265.USD","LU1023059063.AUD","LU0058720904.USD","SG9999002232.USD","LU0456855351.SGD","LU0225284248.USD","LU1066051498.USD","BK4550","IE00BLSP4452.SGD","LU1057294990.SGD","BK4007","LU0868494617.USD","LU0289739699.SGD","LU0122379950.USD","BK4533","IE00BBT3K403.USD","BK4534","LU0225771236.USD","LU0321505868.SGD","IE00BLSP4239.USD","BK4599","BK4585","IE00B19Z3581.USD","LU0306807586.USD","SG9999001176.USD","SG9999013999.USD"],"gpt_icon":0},{"id":"2525926347","title":"Will Weakness in Abbott Laboratories' (NYSE:ABT) Stock Prove Temporary Given Strong Fundamentals?","url":"https://stock-news.laohu8.com/highlight/detail?id=2525926347","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525926347?lang=en_us&edition=fundamental","pubTime":"2025-04-05 19:00","pubTimestamp":1743850818,"startTime":"0","endTime":"0","summary":"It is hard to get excited after looking at Abbott Laboratories'  recent performance, when its stock has declined 9.6% over the past month. However, stock prices are usually driven by a company’s financial performance over the long term, which in this case looks quite promising. Particularly, we will be paying attention to Abbott Laboratories'  ROE today.ROE or return on equity is a useful tool to assess how effectively a company can generate returns on the investment it received from its shareholders. In short, ROE shows the profit each dollar generates with respect to its shareholder investments.Trump has pledged to \"unleash\" American oil and gas and these 15 US stocks have developments that are poised to benefit.Return on equity can be calculated by using the formula:. Return on Equity = Net Profit  ÷ Shareholders' Equity. So, based on the above formula, the ROE for Abbott Laboratories is:. The 'return' refers to a company's earnings over the last year. That means that for every $1 w","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/weakness-abbott-laboratories-nyse-abt-110018369.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0170899867.USD","BK4533","LU1989763427.SGD","IE00B2B36J28.USD","LU1691799644.USD","LU1989763690.USD","LU0122379950.USD","LU1061106388.HKD","ABT","LU0234572021.USD","SGXZ23171101.USD","BK4585","BK4566","BK4581","LU0266013472.USD","BK4588","LU1914381329.SGD","LU2133065610.SGD","LU2237957811.SGD","IE0009355771.USD","IE00BFTCPJ56.SGD","LU1721429741.USD","LU0868494617.USD","LU2237957902.USD","BK4592","SG9999002224.SGD","IE00BJT1NW94.SGD","LU1023059063.AUD","BK4082","BK4568","IE0002141913.USD","LU2468319806.SGD","NYSE","SG9999002232.USD","IE00BJJMRZ35.SGD","LU1057294990.SGD","LU2112291526.USD","LU1721429402.USD","LU2089984988.USD","SG9999004303.SGD","IE00B4R5TH58.HKD","BK4504"],"gpt_icon":0},{"id":"2525302367","title":"BioNTech SE Announces Virtual Annual General Meeting for 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2525302367","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525302367?lang=en_us&edition=fundamental","pubTime":"2025-04-05 04:28","pubTimestamp":1743798520,"startTime":"0","endTime":"0","summary":"BioNTech SE ( ($BNTX) ) has shared an update. On April 4, 2025, BioNTech SE announced the invitation to its Annual General Meeting scheduled for Ma...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/biontech-se-announces-virtual-annual-general-meeting-for-2025?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/biontech-se-announces-virtual-annual-general-meeting-for-2025?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4548","BK4139","BK4568","BNTX","BK4551","BK4585","BK4535","BK4588"],"gpt_icon":0},{"id":"2525737331","title":"The FDA Is Being Gutted. 'People Are Going to Die.' -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2525737331","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525737331?lang=en_us&edition=fundamental","pubTime":"2025-04-05 04:00","pubTimestamp":1743796800,"startTime":"0","endTime":"0","summary":"When Vera Rosenthal left work at the offices of Food and Drug Administration a week ago, she made sure to take home her Dr. Anthony Fauci bobblehead doll.Rosenthal had a hunch layoffs were on the way. \"I was not letting them keep my Fauci bobblehead,\" she says.Massive layoffs passed like a scythe through the FDA this week, part of health secretary Robert F. Kennedy Jr.'s plan to cut as many as 10,000 inside the U.S. Department of Health and Human Services, including 3,500 at FDA.FDA deadlines, called PDUFA dates, are set under agreement between the industry and the FDA, and aren't often missed. Last year, the FDA division responsible for approving new drugs hit its PDUFA goal dates 94% of the time.\"It's possible that RFK wanted to raise additional questions about a vaccine application,\" says David Risinger, an analyst at Leerink Partners. \"It's also possible that it may be a sign that PDUFA dates may not be met, given the turmoil at FDA.\"","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVAX","BK4547","BK4585","BK4588","BK4139","BK4568"],"gpt_icon":0},{"id":"2525731662","title":"AstraZeneca (LSE:AZN) Secures EU Approvals; $125 Million Payment Due to Daiichi Sankyo","url":"https://stock-news.laohu8.com/highlight/detail?id=2525731662","media":"Simply Wall St.","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525731662?lang=en_us&edition=fundamental","pubTime":"2025-04-05 02:09","pubTimestamp":1743790157,"startTime":"0","endTime":"0","summary":"AstraZeneca has seen a shift recently with the EU approval of ENHERTU and Imfinzi, which are likely influential in its 8% share price increase over the last quarter. These regulatory milestones highlight the company's advancements in oncology treatments. Meanwhile, the market has been volatile, with major indices experiencing significant declines amid global trade tensions and economic uncertainty, with the Dow Jones down 4%. Despite this backdrop, AstraZeneca has outperformed, reflecting confidence in its product pipeline and expansion initiatives, bolstered by strategic financial movements like the milestone payment to Daiichi Sankyo.We've spotted 2 possible red flags for AstraZeneca you should be aware of.LSE:AZN Revenue & Expenses Breakdown as at Apr 2025. Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/astrazeneca-lse-azn-secures-eu-180917251.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4156","BK4568","LU0889565916.HKD","LU2236285917.USD","AZN","LU0109394709.USD","LU2417539215.USD","LU2456880835.USD","LU2462157665.USD","LSE","BK4007","LU1829250122.USD","BK4585","BK4588","LU0320765992.SGD","BK4179"],"gpt_icon":0},{"id":"2525691739","title":"European Drug Regulator Approves AstraZeneca's Two Flagship Cancer Drugs For Breast And Lung Cancer Settings","url":"https://stock-news.laohu8.com/highlight/detail?id=2525691739","media":"Benzinga","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525691739?lang=en_us&edition=fundamental","pubTime":"2025-04-05 02:02","pubTimestamp":1743789775,"startTime":"0","endTime":"0","summary":"The European Commission on Friday approved AstraZeneca Plc  and Daiichi Sankyo's Enhertu  as a monotherapy for a type of breast cancer.The approval covers adult patients with unresectable or metastatic hormone receptor -positive, HER2-low or HER2-ultralow breast cancer who have received at least one endocrine therapy in the metastatic setting and who are not considered suitable for endocrine therapy as the next line of treatment.Also Read: FDA Approves AstraZeneca's Imfinzi As First Perioperative Immunotherapy For Muscle-Invasive Bladder Cancer Patients. The approval is based on results from the DESTINY-Breast06 Phase 3 trial.In the trial,Enhertushowed a 38% reduction in the risk of disease progression or death versus chemotherapy in patients with chemotherapy-nave HR-positive, HER2-low metastatic breast cancer with a median progression-free survival  of 13.2 months versus 8.1 months.In the overall trial population, the median PFS was 13.2 months in patients randomized toEnhertucompare","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/european-drug-regulator-approves-astrazenecas-180255396.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4568","BK4007","LU2462157665.USD","ALK","PFS","BK4500","BK4211","LU2236285917.USD","LU0889565916.HKD","BK4203","AZN","OS","BK4588","LU0320765992.SGD","BK4585","LU2456880835.USD","LU0109394709.USD","BK4195","LU2417539215.USD","HR","BK4008","BK4097","BK4225","LU1829250122.USD"],"gpt_icon":0},{"id":"2524784849","title":"BUZZ-US medical device makers fall as China retaliates to US tariffs","url":"https://stock-news.laohu8.com/highlight/detail?id=2524784849","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524784849?lang=en_us&edition=fundamental","pubTime":"2025-04-04 23:21","pubTimestamp":1743780090,"startTime":"0","endTime":"0","summary":"BUZZ-US medical device makers fall as China retaliates to US tariffs**  Shares of U.S. medical device makers fall, along with the broader market, after China imposes 34% retaliatory tariffs on America","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250404:nL6N3QI0J7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BAX","LU0266013472.USD","LU1989771016.USD","BK4566","LU2089984988.USD","BK4588","LU1791710582.SGD","LU0265550946.USD","IE0002141913.USD","SG9999002224.SGD","IE00B2B36J28.USD","BK4534","LU0310799852.SGD","MDT","LU2089284900.SGD","LU0868494617.USD","ABT","LU2362541513.USD","LU0158827781.USD","SYK","SGXZ23171101.USD","LU1791710400.SGD","LU2468319806.SGD","LU1057294990.SGD","LU0528227936.USD","IE00BQXX3C00.GBP","LU1914381329.SGD","LU2362541273.HKD","BK4568","LU0320765489.SGD","LU1983299246.USD","ILMN","BK4585","LU0162691827.USD","LU0070302665.USD","LU1291159041.SGD","IE00BMPRXR70.SGD","LU2125909593.SGD","IE00BQXX3F31.USD","LU1267930490.SGD","SG9999002232.USD","DXCM","GB00B4LPDJ14.GBP","LU0496365809.HKD","LU0882574055.USD","LU1116320901.HKD","LU2089283258.USD","IE00B3T34201.USD","IE00BJT1NW94.SGD","LU1116320737.USD"],"gpt_icon":0},{"id":"2524782992","title":"Pfizer Inc. (PFE) – Jim Cramer Declares: ‘Dead Money – Close the Casket!’","url":"https://stock-news.laohu8.com/highlight/detail?id=2524782992","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524782992?lang=en_us&edition=fundamental","pubTime":"2025-04-04 22:45","pubTimestamp":1743777929,"startTime":"0","endTime":"0","summary":"We recently published a list of Jim Cramer’s Lightning Round: 8 Stocks in Focus. In this article, we are going to take a look at where Pfizer Inc.  stands against other stocks that Jim Cramer discusses.Jim Cramer, host of Mad Money, discussed on Monday how investor sentiment surrounding tech stocks has shifted over the past three months. He pointed out that not long ago, tech was seen as the leader of the market. However, that is no longer the case. Cramer noted that he had hoped for a thriving AI infrastructure space.“Three months ago, I thought we could be in for all sorts of exciting new technology. We went out to that GTC conference with Jensen Huang, but so far this year AI has only evolved in the direction of lower stock prices.”READ ALSO:Jim Cramer Looked At These 23 Stocks RecentlyandJim Cramer Put These 16 Stocks Under a Microscope.Why are we interested in the stocks that hedge funds pile into?","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/pfizer-inc-pfe-jim-cramer-144529049.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4581","LU1894683348.USD","IE00BLSP4452.SGD","SGXZ57979304.SGD","IE0002270589.USD","SG9999001176.SGD","LU1057294990.SGD","SG9999002224.SGD","LU0122379950.USD","IE00B19Z3B42.SGD","BK4534","LU0225284248.USD","IE00B19Z3581.USD","LU0289739699.SGD","LU0868494617.USD","SG9999011175.SGD","IE00BBT3K403.USD","BK4599","SG9999013999.USD","LU0306807586.USD","BK4592","BK4533","LU0170899867.USD","BK4007","BK4585","IE00BLSP4239.USD","SG9999002232.USD","LU1894683264.USD","LU0225771236.USD","PFE","LU1883839398.USD","SG9999001176.USD","LU0058720904.USD","BK4588","LU1023059063.AUD","LU0234572021.USD","LU0985481810.HKD","BK4568","IE000M9KFDE8.USD","LU0321505868.SGD","LU1066053197.SGD","LU0321505439.SGD","LU1066051498.USD","LU0306806265.USD","LU0456855351.SGD","BK4550","SG9999003800.SGD"],"gpt_icon":1},{"id":"2524781005","title":"Is Abbott (ABT) a Buy as Wall Street Analysts Look Optimistic?","url":"https://stock-news.laohu8.com/highlight/detail?id=2524781005","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524781005?lang=en_us&edition=fundamental","pubTime":"2025-04-04 21:30","pubTimestamp":1743773410,"startTime":"0","endTime":"0","summary":"The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed  analysts changing their ratings often affect a stock's price. Do they really matter, though?Before we discuss the reliability of brokerage recommendations and how to use them to your advantage, let's see what these Wall Street heavyweights think about Abbott .Abbott currently has an average brokerage recommendation  of 1.56, on a scale of 1 to 5 , calculated based on the actual recommendations  made by 25 brokerage firms. An ABR of 1.56 approximates between Strong Buy and Buy.Of the 25 recommendations that derive the current ABR, 17 are Strong Buy and two are Buy. Strong Buy and Buy respectively account for 68% and 8% of all recommendations.Analysts employed by brokerage firms have been and continue to be overly optimistic with their recommendations. Since the ratings issued by these analysts are more favora","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/abbott-abt-buy-wall-street-133010470.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4533","BK4588","LU0234572021.USD","BK4568","SG9999002232.USD","IE0009355771.USD","BK4581","LU2089984988.USD","LU1989763427.SGD","BK4110","LU0266013472.USD","LU0868494617.USD","LU2133065610.SGD","IE00B4R5TH58.HKD","BK4566","BK4504","LU2237957811.SGD","LU1057294990.SGD","LU1721429741.USD","SG9999002224.SGD","IE0002141913.USD","IE00BJJMRZ35.SGD","SGXZ23171101.USD","LU2468319806.SGD","LU1989763690.USD","LU1061106388.HKD","BK4082","LU0170899867.USD","ABR","ABT","LU1914381329.SGD","SG9999004303.SGD","LU2112291526.USD","IE00BFTCPJ56.SGD","LU1721429402.USD","LU1023059063.AUD","LU0122379950.USD","LU2237957902.USD","IE00B2B36J28.USD","BK4585","BK4592","LU1691799644.USD","IE00BJT1NW94.SGD"],"gpt_icon":0},{"id":"2524010412","title":"Almonty Industries Inc. Confirms No Impact from Recent U.S. Executive Order on Reciprocal Tariffs","url":"https://stock-news.laohu8.com/highlight/detail?id=2524010412","media":"Business Wire","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524010412?lang=en_us&edition=fundamental","pubTime":"2025-04-04 21:02","pubTimestamp":1743771720,"startTime":"0","endTime":"0","summary":"TORONTO, April 04, 2025----Almonty Industries Inc.     , a leading global producer of tungsten concentrate, is pleased to confirm that, based on currently available information, its operations and product exports are not affected by the recent Executive Order issued by the United States government regarding reciprocal tariffs on select imports.The Executive Order published on April 2, 2025, outlines new tariff measures targeting specific Harmonized Tariff Schedule  codes. Following a detailed review of Annex I and Annex II of the order titled \"Regulating Imports with a Reciprocal Tariff to Rectify Trade Practices that Contribute to Large and Persistent Annual United States Goods Trade Deficits,\" we can confirm that Almonty's tungsten ore, concentrates, oxide, and related materials are not subject to the newly imposed tariffs. These products — including those classified under HTS codes 2611.00.30, 2611.00.60, and 2825.90.30 — are explicitly excluded from the action, as listed in Annex I","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/almonty-industries-inc-confirms-no-130200291.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["BK4168","APT","BK7095","APT.AU","ALMTF","BK4086","BK4568","AII.AU"],"gpt_icon":0},{"id":"2524201284","title":"Lakeland Industries (LAKE) Receives a Buy from Roth MKM","url":"https://stock-news.laohu8.com/highlight/detail?id=2524201284","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524201284?lang=en_us&edition=fundamental","pubTime":"2025-04-04 20:56","pubTimestamp":1743771364,"startTime":"0","endTime":"0","summary":"Roth MKM analyst Gerry Sweeney maintained a Buy rating on Lakeland Industries (LAKE – Research Report) today and set a price target of $29.00. The ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/lakeland-industries-lake-receives-a-buy-from-roth-mkm-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/lakeland-industries-lake-receives-a-buy-from-roth-mkm-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B19Z4B17.USD","BK4202","BK4568","IE00B66KJ199.SGD","IE0031619046.USD","IE00B7SZL793.SGD","LAKE"],"gpt_icon":0},{"id":"2524783657","title":"4 Low-Beta Healthcare Stocks to Beat Trump's Tariff Blues","url":"https://stock-news.laohu8.com/highlight/detail?id=2524783657","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524783657?lang=en_us&edition=fundamental","pubTime":"2025-04-04 20:27","pubTimestamp":1743769620,"startTime":"0","endTime":"0","summary":"As expected, Wall Street came crashing down on Thursday after President Donald Trump announced his sweeping tariffs, raising the risk of a global trade war that could push the economy into recession.All three major indexes recorded one of their worst days in years, with the S&P 500 slipping back into correction territory. Markets have been volatile since February, and the bloodbath that began early this month could continue for a longer period as fears of a recession continue to dent their sentiments.The stocks are also from the low-beta category . Hence, the recommended approach is to invest in low-beta stocks with a high dividend yield and a favorable Zacks Rank.Wall Street Rattled by Trump’s Tariff Announcement. Trump’s harsh tariffs saw a bloodbath on Wall Street, with the S&P 500 declining 4.8% to record its worst day since June 2020. The Dow tumbled 1,679.39 points, or 4%, also registering its worst day since June 2020. The tech-heavy Nasdaq fell 6% to record its worst day since ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/4-low-beta-healthcare-stocks-122700398.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1571399168.USD","SSO","LU1430594728.SGD","OEF","US3Y.BOND","LU0889565916.HKD","BK4534","SPY","US12M.BOND","US10Y.BOND","SH","FMS","SDS","BK4082","IVV","LU1839511570.USD",".SPX","BK4532","COR","LU2324357040.USD","US6M.BOND","IE00B3T34201.USD","BK4588","IE0002270589.USD","IE00BKVL7J92.USD","BK4568","GILD","US2Y.BOND","OEX","SGXZ23171101.USD","BK4566","LU1261432733.SGD","BK4504","VOO","US30Y.BOND","SPXU","BK4581","LU0289739699.SGD","LMAT","BK4084","ESmain","HCSG","IE00BSNM7G36.USD","IE00B19Z3B42.SGD","US7Y.BOND","BK4137","US5Y.BOND","LU2237957811.SGD","BK4559"],"gpt_icon":1},{"id":"2524785706","title":"Reasons to Add ABT Stock to Your Portfolio Right Now","url":"https://stock-news.laohu8.com/highlight/detail?id=2524785706","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524785706?lang=en_us&edition=fundamental","pubTime":"2025-04-04 20:09","pubTimestamp":1743768540,"startTime":"0","endTime":"0","summary":"Abbott Laboratories’ ABT strong sales recovery within the Nutrition business, driven by the robust sales performance of Ensure, is poised to drive growth in the upcoming quarters. The company is driving solid growth in emerging markets within the EPD business. Within Diabetes Care, ABT is driving robust growth through its flagship, sensor-based CGM system — FreeStyle Libre. However, currency fluctuations may restrict Abbott’s growth potential.In the past year, this Zacks Rank #2  company’s shares have risen 19.6% compared with the industry’s 9.1% growth and the S&P 500 composite’s 5.4% increase.EPD Set for Sustainable Growth: Abbott’s EPD is well-positioned for sustained growth in emerging pharmaceutical markets, leveraging the successful execution of its Branded Generic operating model. The company continues to sustain its long-standing track record of delivering strong growth, which includes a five-year compound annual growth rate  of 8% for EPD.In the fourth quarter of 2024, the com","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/reasons-add-abt-stock-portfolio-120900803.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2237957902.USD","LU2468319806.SGD","CAH","LU0187121727.USD","LU1989772840.SGD","LU0267386448.USD","LU0162691827.USD","LU1267930813.SGD","LU2237957811.SGD","CAGR","LU2491050071.SGD","LU0077335932.USD","LU1983299246.USD","BK4504","LU1791710400.SGD","LU2506952097.USD","PAHC","LU1989764748.USD","IE0002141913.USD","LU0128525689.USD","LU2506951875.HKD","BSX","LU2506952170.USD","SG9999002232.USD","LU2244417387.USD","BK4007","BK4581","BK4566","LU0310799852.SGD","LU2087625088.SGD","LU0353189763.USD","LU2362541273.HKD","LU1880398554.USD","IE00B2B36J28.USD","BK4175","LU0950375773.USD","LU1721429402.USD","BK4568","LU0823417737.USD","LU1571399168.USD","LU0310800965.SGD","LU0048584097.USD","LU2324357040.USD","BK4533","LU0868494617.USD","LU1267930227.SGD","LU0882574055.USD","ABT","LU0528227936.USD","LU0011850046.USD"],"gpt_icon":0},{"id":"2524067852","title":"TREMFYA® (guselkumab) is the first and only IL-23 inhibitor to significantly reduce both the signs and symptoms and the progression of structural damage in adults living with active psoriatic arthritis","url":"https://stock-news.laohu8.com/highlight/detail?id=2524067852","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524067852?lang=en_us&edition=fundamental","pubTime":"2025-04-04 20:05","pubTimestamp":1743768300,"startTime":"0","endTime":"0","summary":"TREMFYA demonstrated clinically meaningful and statistically significant efficacy in patients with active psoriatic arthritis at risk for structural damage in Phase 3b study. Topline results demonstrate efficacy across multiple domains at Week 24, reinforcing TREMFYA as a first-line treatment option for patients with active psoriatic arthritis. SPRING HOUSE, Pa., April 4, 2025 /PRNewswire/ -- Johnson & Johnson  today announced that the TREMFYA  Phase 3b APEX study achieved both its primary endpoint  of reducing signs and symptoms and its major secondary endpoint of reducing progression of structural damage as measured by radiographic progression at 24 weeks, in adults living with active psoriatic arthritis , compared to placebo.1. In the Phase 3b APEX study, TREMFYA-treated patients also exhibited significantly less progression of structural damage versus patients receiving placebo at Week 24 as assessed by the PsA modified van der Heijde-Sharp  score, which includes joint space narrow","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/tremfya-guselkumab-first-only-il-120500976.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/tremfya-guselkumab-first-only-il-120500976.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1732799900.SGD","JNJ","LU0122379950.USD","BK4532","IE00BDGV0183.EUR","LU2112291526.USD","LU0320765646.SGD","LU1935042991.SGD","IE0002141913.USD","LU0114720955.EUR","BK4533","IE000M9KFDE8.USD","BK4504","IE0034235303.USD","IE00B19Z3581.USD","LU1059921491.USD","LU0640476718.USD","LU1032955483.USD","IE00B3PB1722.GBP","LU2089984988.USD","BK4592","LU0203345920.USD","LU0203347892.USD","IE00BJT1NW94.SGD","LU1244550221.USD","BK4588","LU1674673691.USD","IE0002270589.USD","SG9999002232.USD","LU1778281490.HKD","LU0882574055.USD","IE00B1BXHZ80.USD","IE00BFTCPJ56.SGD","BK4559","LU1894683264.USD","LU1023059063.AUD","IE00B19Z3B42.SGD","LU0345769631.USD","IE00B3T34201.USD","LU0234572021.USD","LU1914381329.SGD","LU1244550494.USD","LU1162221912.USD","LU0792757196.USD","LU2602419157.SGD","LU0889566641.SGD","LU1261432733.SGD","LU1506573853.SGD","BK4568","BK4550"],"gpt_icon":1},{"id":"2524030352","title":"AstraZeneca PLC's (LON:AZN) Stock Has Fared Decently: Is the Market Following Strong Financials?","url":"https://stock-news.laohu8.com/highlight/detail?id=2524030352","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524030352?lang=en_us&edition=fundamental","pubTime":"2025-04-04 19:19","pubTimestamp":1743765588,"startTime":"0","endTime":"0","summary":"AstraZeneca's  stock up by 7.5% over the past three months. Since the market usually pay for a company’s long-term financial health, we decided to study the company’s fundamentals to see if they could be influencing the market. In this article, we decided to focus on AstraZeneca's  ROE.Return on Equity or ROE is a test of how effectively a company is growing its value and managing investors’ money. In simpler terms, it measures the profitability of a company in relation to shareholder's equity.AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.So, based on the above formula, the ROE for AstraZeneca is:","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/astrazeneca-plcs-lon-azn-stock-111948924.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1829250122.USD","AZN","LU2417539215.USD","LU0109394709.USD","BK4585","BK4588","BK4007","LU2456880835.USD","LU2462157665.USD","BK4568","LU0320765992.SGD","LU0889565916.HKD","LU2236285917.USD"],"gpt_icon":0},{"id":"2524047932","title":"Thermo Fisher Stock Benefits From the Launch of Krios 5 Cryo-TEM","url":"https://stock-news.laohu8.com/highlight/detail?id=2524047932","media":"Zacks","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524047932?lang=en_us&edition=fundamental","pubTime":"2025-04-04 18:51","pubTimestamp":1743763860,"startTime":"0","endTime":"0","summary":"Thermo Fisher Scientific TMO has unveiled its latest customer-centric innovation, the Thermo Scientific Krios 5 Cryo-Transmission Electron Microscope . The next-generation atomic-resolution platform uses enhanced optics and AI-enabled automation to study molecular structures and interactions at throughput and fidelity that was previously out of reach.The development is expected to bolster the company’s Materials and Structural Analysis business unit.After the announcement on April 2, Thermo Fisher’s shares inched up 1.3%, finishing the session at $489.06. The new Krios 5 Cryo-TEM reflects the company’s focus on customer-driven innovations. By providing unmatched automation and throughput, it enables researchers and the pharmaceutical industry to uncover new insights and fight diseases better than ever before. Hence, we expect the latest news to positively influence the market sentiment for TMO stock.A research reportestimates that the global cryo-EM market will reach $1.45 billion in 2","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/thermo-fisher-stock-benefits-launch-105100922.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0170899867.USD","TMO","LU2506952097.USD","LU0234572021.USD","LU2362541513.USD","BK4534","IE00B19Z9505.USD","LU2063271972.USD","LU1815333072.USD","IE00B19Z8X17.USD","LU2506951958.HKD","LU0316494557.USD","LU1989772840.SGD","LU0353189763.USD","BK4585","LU2089984988.USD","LU2264538146.SGD","LU0048584097.USD","LU1548497426.USD","LU1989763427.SGD","LU2041044095.USD","LU2237957811.SGD","LU1861559042.SGD","BK4568","LU0823417653.USD","SG9999002224.SGD","ABT","LU2360108059.USD","LU2133065610.SGD","LU0077335932.USD","LU1923621640.USD","IE00BFTCPJ56.SGD","BSX","LU0225283273.USD","LU1623119135.USD","LU1988902786.USD","LU2242649171.HKD","LU2092937221.SGD","IE0002141913.USD","LU0238689110.USD","LU2125910179.SGD","LU0353189680.USD","LU1291159041.SGD","IE00BKPKM429.USD","LU2125909593.SGD","BK4581","LU0345769631.USD","LU2764263203.CNY"],"gpt_icon":1}],"pageSize":20,"totalPage":14,"pageCount":1,"totalSize":266}]}}